丙泊酚通过调控miR-574-5p/SOX2表达抑制胃癌AGS细胞增殖、侵袭和迁移
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Propofol inhibits the proliferation, invasion and migration of gastric cancer AGS cells by regulating the expression of miR-574-5p/Sox2
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨丙泊酚通过调控微小RNA-574-5P(miRNA-574-5P)/性别决定区Y框蛋白(SOX2)对胃癌AGS细胞增殖、侵袭和迁移的影响和分子机制。 方法 以0、5、10和20 μg/mL丙泊酚处理AGS细胞48 h。筛选丙泊酚最佳使用浓度。将转染后的AGS细胞分为对照组、丙泊酚组、丙泊酚+miR-NC组、丙泊酚+miR-574-5p组、丙泊酚+si-con组、丙泊酚+si-SOX2组、丙泊酚+miR-574-5p+pcDNA组、丙泊酚+miR-574-5p+ pcDNA-SOX2组。采用细胞计数(CCK-8)法检测细胞增殖;克隆形成实验检测细胞克隆形成能力;Transwell实验检测细胞侵袭和迁移;实时荧光定量聚合酶链反应(PCR)法检测细胞中微小RNA(miR)-574-5p的表达水平;免疫印迹法检测细胞中SOX2蛋白的表达水平。采用上述方法检测AGS细胞增殖、侵袭、迁移能力。双荧光素酶报告基因实验检测miR-574-5p与SOX2的靶向关系。 结果 选择20 μg/mL丙泊酚浓度进行实验。与0μg/mL比较,5、10、20 μg/mL丙泊酚处理组细胞存活率、克隆形成率、侵袭细胞数和迁移细胞数均明显降低(P<0.05),且呈浓度依赖性,miR-574-5P表达水平呈浓度依赖性降低,SOX2呈浓度依赖性升高(P<0.05)。与对照组比较,丙泊酚组AGS细胞存活率、克隆形成率、迁移和侵袭细胞数以及miR-574-5p表达显著降低(均P<0.05),SOX2蛋白表达显著升高(P<0.05)。与丙泊酚+miR-NC组比较,丙泊酚+miR-574-5p组AGS细胞存活率、克隆形成率、迁移和侵袭细胞数以及miR-574-5p表达显著升高(均P<0.05),SOX2蛋白表达显著降低(P<0.05)。与丙泊酚+si-con组比较,丙泊酚+si-SOX2组AGS细胞存活率、克隆形成率、迁移和侵袭细胞数以及miR-574-5p表达显著升高(均P<0.05),SOX2蛋白表达显著降低(P<0.05)。与丙泊酚+miR-574-5p+pcDNA组比较,丙泊酚+miR-574-5p+ pcDNA-SOX2组AGS细胞存活率、克隆形成率、迁移和侵袭细胞数以及miR-574-5p表达显著降低(均P<0.05),SOX2蛋白表达显著升高(P<0.05)。miR-574-5p直接与SOX2结合。 结论 丙泊酚通过调控miR-574-5p/SOX2表达抑制胃癌AGS细胞增殖、侵袭和迁移。

    Abstract:

    【Abstract】 Objective To investigate the effect and the molecular mechanism of propofol on the proliferation, invasion and migration of gastric cancer AGS cells. Methods AGS cells were treated with propofol at 5, 10 and 20 μg/mL for 48 hours. Cell proliferation was detected by CCK-8 method. Cell cloning ability was detected by clone formation assays. Cell invasion and migration were detected by Transwell assays. Rxpression of miR-574-5p was detected by realtime fluorescence quantitative PCR and expression of SOX2 protein was detected by western blotting. The optimal concentration of propofol was screened. AGS cells were divided into control group, propofol group, propofol+miR-NC group, propofol+miR-574-5p group, propofol+si-con group, propofol+si-SOX2 group, propofol+miR-574-5p+pcDNA group, propofol+miR-574-5p+ pcDNA-SOX2 group, and the above methods were used to detect the proliferation, invasion and migration ability of AGS cells. The dual luciferase reporter gene experiment was ferformed to detect the targeting relationship between miR-574-5p and SOX2. Results The concentration of 20 μg/mL propofol was selected for the experiment. Compared with the control group, the cell survival rate, clone formation rate, migration and invasion cell numbers and miR-574-5p expression of AGS cells in the propofol group were significantly reduced, whereas SOX2 protein expression was significantly increased (P<0.05). Compared with the propofol+miRNC group, the cell survival rate, clone formation rate, migration and invasion cell numbers and miR-574-5p expression of AGS cells were in the propofol+miR-574-5p group were significantly increased, whereas SOX2 protein expression was significantly decrease (P<0.05). Compared with the propofol+si-con group, the cell survival rate, clone formation rate, migration and invasion cell numbers and miR-574-5p expression of AGS cells in the propofol+si-SOX2 group were significantly increased, whereas SOX2 protein expression was significantly decreased (P<0.05). Compared with the propofol+miR-574-5p+pcDNA group, the cell survival rate, clone formation rate, migration and invasion cell numbers and miR-574-5p expression of AGS cells in the propofol+miR-574-5p+pcDNA-SOX2 group were significant decrease, whereas SOX2 protein expression was significantly increased (P<0.05). miR-574-5p binds directly to SOX2. Conclusion Propofol inhibits the proliferation, invasion and migration of gastric cancer AGS cells by regulating the expression of miR-574-5p/SOX2.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-02
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司